Page 53 - THE COVID-19 CHRONICLES OF MALAYSIA Embracing Ripples: Coursing Forward
P. 53

Reporting of AEFI
 For Optimal Protection, Mix & Match


                22 January 2022: Serious
 21 January 2022: Mix and Match Please Recipients of the full dose of Sinovac vaccine   AEFI for a Booster Dose is   23,427  (AEFI)
 (CoronaVac®) are strongly encouraged to take either AstraZeneca vaccine   Rare NPRA AEFI Reporting
 (Covishield®/Vaxzevria®) or Pfizer-BioNTech vaccine (Comirnaty®) as booster doses   System shows that there
 for optimal protection.    §  are 51 cases with serious
                side effect out of

                10,192,887 booster doses                    Booster dose
                that were administrated,                 10,192,887      1st&2nd dose  51,530,767
                equivalent to 0.005 reports
                per 1,000 doses.    §             51  (Serious cases)
                                                      984  (AEFI)




                 Channels to Report AEFI Vaccine recipients could report AEFI via ConSERF on the
                 NPRA website while healthcare workers could report through the NPRA website or
                 Pharmacy Information System (PhIS) for MOH facilities.    §




 Source: KJ Twitter    §
 Malaysia-Singapore VTL Resumed VTL between the 2 countries will be resumed today,
 with the ticket quota limited to 50% capacity of the bus and flight.    §









                                                                                  Source: NPRA  Portal    §





 Source: New China TV Youtube    §












                                                                                  Source: PhIS Portal    §
                                                                                              23
 Source: CNA News    §
   48   49   50   51   52   53   54   55   56   57   58